Suomeksi

L-carnitine: dosage in studies

Updated 15 Oct 2026 Author: About 2 min read Drafted with the help of AI; sources and claims checked separately.

Not a recommendation, not treatment guidance. This page shows only what published human studies used, with sources. This site does not say how much anyone should use of any substance. Fimea warns against using injectable peptides bought online: Fimea warning.

L-carnitine has no authorised medicinal product in Finland or centrally in the EU, so there is no approved dosage in Finland [10]regulator.

In the randomised trials in the table, L-carnitine was used at 2 g a day [2, 4, 5]A, and in the muscle study 2 g L-carnitine L-tartrate with 80 g carbohydrate twice a day [3]A, for four weeks to six months. In the heart attack trial it was first given into a vein in hospital and then by mouth for a year [1]A.

In the studies of an exercise review, the long-term amount was 1-3 g a day and a single dose 3-4 g [12]B.

Doses used in studies

Doses used in published human studies. Not a recommendation.
StudyParticipantsDoseFrequencyDurationSource and level
CEDIM, Iliceto 1995 472 patients with a first anterior heart attack (233 received L-carnitine) 9 g a day into a vein, then 6 g a day by mouth Daily 5 days into a vein, then 12 months by mouth [1]A
Cruciani 2012 (ECOG, phase III) 376 people with cancer and fatigue 2 g a day by mouth Daily 4 weeks [2]A
Wall 2011 14 healthy men 2 g L-carnitine L-tartrate with 80 g carbohydrate by mouth Twice a day 24 weeks [3]A
Lenzi 2004 60 infertile men aged 20-40 2 g L-carnitine and 1 g acetyl-L-carnitine a day (route not stated in the abstract) Daily 6 months [4]A
Sigman 2006 21 infertile men (12 received carnitine) 2,000 mg L-carnitine and 1,000 mg acetyl-L-carnitine a day by mouth Daily 24 weeks [5]A
Krims-Davis 2025 (open-label) Healthy volunteers (11 and 12 people) 0.5 or 1.5 g by mouth Single dose 48 hours of follow-up [6]B

Evidence levels: regulator = a regulator's assessment or decision, not research evidence · A = randomised human trial or meta-analysis · B = observational human study or case series · C = animal study · D = cell or laboratory study · E = not peer-reviewed

Notes

According to a pharmacokinetic review, only 5-18% of oral doses of 1-6 grams is absorbed [9]B, so amounts taken by mouth and given into a vein cannot be compared directly.

In the fertility trials L-carnitine was given together with acetyl-L-carnitine, so the share of L-carnitine alone cannot be separated [4, 5]A. In the muscle study the comparison group took carbohydrate alone, so the result shows the effect of adding carnitine to carbohydrate, not of carnitine on its own [3]A.

In the single-dose study, the measured L-carnitine content of the capsules was 86% of the amount stated by the manufacturer [6]B.

What points the other way or is uncertain

In people with cancer, 2 g a day for four weeks did not ease fatigue more than placebo [2]A, and a meta-analysis of good-quality studies found no effect [8]A.

In CEDIM 2 (2,330 heart attack patients), the combined number of deaths and heart failure over six months did not differ from placebo [7]A.

In Sigman 2006, the same combination that improved sperm motility in Lenzi 2004 did not improve it [4, 5]A, and a meta-analysis of 50 trials found no effect of supplements on pregnancies [13]A.

More on this

Read the research yourself: sources

  1. Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol. 1995;26(2):380-7. PMID 7608438
  2. Cruciani RA, Zhang JJ, Manola J, et al. L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2012;30(31):3864-9. PMID 22987089
  3. Wall BT, Stephens FB, Constantin-Teodosiu D, et al. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol. 2011;589(Pt 4):963-73. PMID 21224234
  4. Lenzi A, Sgrò P, Salacone P, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81(6):1578-84. PMID 15193480
  5. Sigman M, Glass S, Campagnone J, et al. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril. 2006;85(5):1409-14. PMID 16600222
  6. Krims-Davis K, Ozola M, Razzivina V, et al. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism. Mol Nutr Food Res. 2025;69(24):e70316. PMID 41243468
  7. Tarantini G, Scrutinio D, Bruzzi P, et al. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology. 2006;106(4):215-23. PMID 16685128
  8. Marx W, Teleni L, Opie RS, et al. Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis. Nutrients. 2017;9(11):1224. PMID 29112178
  9. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet. 2003;42(11):941-67. PMID 12908852
  10. European Medicines Agency. Article 57 product data (EMA/518502/2018 Rev.90, data as of 9 Oct 2026): levocarnitine entries in 12 EU countries and Northern Ireland; none for Finland and no centrally authorised (EU) product. EMA
  11. Hathcock JN, Shao A. Risk assessment for carnitine. Regul Toxicol Pharmacol. 2006;46(1):23-8. PMID 16901595
  12. Mielgo-Ayuso J, Pietrantonio L, Viribay A, et al. Effect of Acute and Chronic Oral l-Carnitine Supplementation on Exercise Performance Based on the Exercise Intensity: A Systematic Review. Nutrients. 2021;13(12):4359. PMID 34959912
  13. Michaelsen MP, Poulsen M, Bjerregaard AA, et al. The Effect of Dietary Supplements on Male Infertility in Terms of Pregnancy, Live Birth, and Sperm Parameters: A Systematic Review and Meta-Analysis. Nutrients. 2025;17(10):1710. PMID 40431450

Sources checked in PubMed on 15 Oct 2026. Participant numbers and the measured capsule content in Krims-Davis 2025 [6] are from the full text of the study; other figures are from the abstracts.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.